Access to anti-retroviral drugs, female in Gabon

Gabon: Access to anti-retroviral drugs, female was 63.0% in 2024. ◆ Volatile

Latest (2024)
63.0%
Change on year
up 10.5%
World rank
96th
of 141 countries
All-time high
63.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Gabon, 2000–2024

02040602000201220242000: 0 %2001: 0 %2002: 1 %2003: 1 %2004: 4 %2005: 9 %2006: 10 %2007: 12 %2008: 14 %2009: 18 %2010: 19 %2011: 26 %2012: 32 %2013: 38 %2014: 40 %2015: 41 %2016: 41 %2017: 42 %2018: 43 %2019: 45 %2020: 46 %2021: 48 %2022: 53 %2023: 57 %2024: 63 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, female in Gabon stood at 63.0%. That is the highest value across all 25 years on record.

That represents a change of up 10.5% on the previous year and up 57.5% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Gabon peaked at 63.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Gabon 96th out of 141 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in Gabon, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Gabon, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 1.0%
2003 1.0% +0.0%
2004 4.0% +300.0%
2005 9.0% +125.0%
2006 10.0% +11.1%
2007 12.0% +20.0%
2008 14.0% +16.7%
2009 18.0% +28.6%
2010 19.0% +5.6%
2011 26.0% +36.8%
2012 32.0% +23.1%
2013 38.0% +18.8%
2014 40.0% +5.3%
2015 41.0% +2.5%
2016 41.0% +0.0%
2017 42.0% +2.4%
2018 43.0% +2.4%
2019 45.0% +4.7%
2020 46.0% +2.2%
2021 48.0% +4.3%
2022 53.0% +10.4%
2023 57.0% +7.5%
2024 63.0% +10.5%

Averages by decade

DecadeAverage LowestHighest Years
2000s 6.9% 0.0% 18.0% 10
2010s 36.7% 19.0% 45.0% 10
2020s 53.4% 46.0% 63.0% 5

Countries ranked near Gabon

  1. 95 Albania 64.0% compare
  2. 96 Chile 63.0% compare
  3. 96 Slovakia 63.0% compare
  4. 99 Bolivia, Plurinational State of 62.0% compare
  5. 99 Jamaica 62.0% compare
  6. 99 Republic of Moldova 62.0% compare
  7. 99 Suriname 62.0% compare

See the full ranking of 160 places →

More gender data for Gabon

All data for Gabon →

Frequently asked questions

What is access to anti-retroviral drugs, female in Gabon?
Access to anti-retroviral drugs, female in Gabon was 63.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Gabon?
The highest recorded value was 63.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Gabon?
The lowest recorded value was 0.0% in 2000.
How does Gabon rank for access to anti-retroviral drugs, female?
Gabon ranks 96th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Gabon?
Over the last ten years it is up 57.5%. The long-run trend across the full record is volatile.
Where does this Gabon data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Gabon. Statizoid, drawing on UNAIDS estimates. Retrieved 08 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/gabon/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/gabon/">Access to anti-retroviral drugs, female in Gabon</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.